223 related articles for article (PubMed ID: 22035276)
1. The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
Gudjónsson S; Bläckberg M; Chebil G; Jahnson S; Olsson H; Bendahl PO; Månsson W; Liedberg F
BJU Int; 2012 Jul; 110(2 Pt 2):E41-5. PubMed ID: 22035276
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
3. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
4. The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
Gaya JM; Matulay J; Badalato GM; Holder DD; Hruby G; McKiernan J
Can J Urol; 2014 Apr; 21(2):7228-33. PubMed ID: 24775577
[TBL] [Abstract][Full Text] [Related]
5. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
[TBL] [Abstract][Full Text] [Related]
6. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of denuded urothelium in bladder biopsy.
Levi AW; Potter SR; Schoenberg MP; Epstein JI
J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
[TBL] [Abstract][Full Text] [Related]
10. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
11. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
12. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
13. [Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens].
Plante P; Lesourd A; Blanchet P; Castagnola C; Coloby P; Daffer N; Davin JL; Desgrandchamps F; Irani J; Marechal JM; Mottet N; Pariente JL
Prog Urol; 1998 Feb; 8(1):47-50. PubMed ID: 9533151
[TBL] [Abstract][Full Text] [Related]
14. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
Donat SM; Wei DC; McGuire MS; Herr HW
J Urol; 2001 May; 165(5):1580-4. PubMed ID: 11342921
[TBL] [Abstract][Full Text] [Related]
16. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Lightfoot AJ; Rosevear HM; Nepple KG; O'Donnell MA
Int J Urol; 2012 Nov; 19(11):988-93. PubMed ID: 22762480
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
[TBL] [Abstract][Full Text] [Related]
18. The value of cystoscopy, prostate biopsy and frozen-section urethral biopsy prior to orthotopic neobladder substitution.
Bulbul MA; Wazzan W; Nasr R; Hemady K
Can J Urol; 2001 Jun; 8(3):1290-2. PubMed ID: 11423017
[TBL] [Abstract][Full Text] [Related]
19. Comparative pathology of dome and trigone of urinary bladder mucosa in paraplegics and tetraplegics.
van Velzen D; Krishnan KR; Parsons KF; Soni BM; Fraser MH; Howard CV; Vaidyanathan S
Paraplegia; 1995 Oct; 33(10):565-72. PubMed ID: 8848310
[TBL] [Abstract][Full Text] [Related]
20. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
